참고문헌
- Chen Z, Li S, Subramaniam S, Shyy JY and Chien S (2017) Epigenetic Regulation: A new frontier for biomedical engineers. Annu Rev Biomed Eng 19, 195-219 https://doi.org/10.1146/annurev-bioeng-071516-044720
- Hyun K, Jeon J, Park K and Kim J (2017) Writing, erasing and reading histone lysine methylations. Exp Mol Med 49, e324 https://doi.org/10.1038/emm.2017.11
- Herz HM, Garruss A and Shilatifard A (2013) SET for life: biochemical activities and biological functions of SET domaincontaining proteins. Trends Biochem Sci 38, 621-639 https://doi.org/10.1016/j.tibs.2013.09.004
- Fritsch L, Robin P, Mathieu JR et al (2010) A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol Cell 37, 46-56 https://doi.org/10.1016/j.molcel.2009.12.017
- Casciello F, Windloch K, Gannon F and Lee JS (2015) Functional role of G9a histone methyltransferase in cancer. Front Immunol 6, 487 https://doi.org/10.3389/fimmu.2015.00487
- Kondo Y, Shen L, Suzuki S et al (2007) Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol Res 37, 974-983 https://doi.org/10.1111/j.1872-034X.2007.00141.x
- Yokoyama M, Chiba T, Zen Y et al (2017) Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma. Oncotarget 8, 21315-21326 https://doi.org/10.18632/oncotarget.15528
- Wei L, Chiu DK, Tsang FH et al (2017) Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J Hepatol 67, 758-769 https://doi.org/10.1016/j.jhep.2017.05.015
- Kim SY, Hong M, Heo SH et al (2018) Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen speciesmediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation. Mol Carcinog 57, 1492-1506 https://doi.org/10.1002/mc.22872
- Esteve PO, Chin HG, Smallwood A et al (2006) Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 20, 3089-3103 https://doi.org/10.1101/gad.1463706
- Jones PA and Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428 https://doi.org/10.1038/nrg816
- Park SE, Yi HJ, Suh N et al (2016) Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-kappaB. Oncotarget 7, 39796-39808 https://doi.org/10.18632/oncotarget.9290
- Stewart MD, Li J and Wong J (2005) Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol Cell Biol 25, 2525-2538 https://doi.org/10.1128/MCB.25.7.2525-2538.2005
- Kim Y, Kim YS, Kim DE et al (2013) BIX-01294 induces autophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy 9, 2126-2139 https://doi.org/10.4161/auto.26308
- Huang Y, Zou Y, Lin L, Ma X and Huang X (2017) Effect of BIX-01294 on proliferation, apoptosis and histone methylation of acute T lymphoblastic leukemia cells. Leuk Res 62, 34-39 https://doi.org/10.1016/j.leukres.2017.09.015
- Sancak Y, Peterson TR, Shaul YD et al (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501 https://doi.org/10.1126/science.1157535
- Kim E, Goraksha-Hicks P, Li L, Neufeld TP and Guan KL (2008) Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 10, 935-945 https://doi.org/10.1038/ncb1753
- Jewell JL, Russell RC and Guan KL (2013) Amino acid signalling upstream of mTOR. Nat Rev Mol Cell Biol 14, 133-139 https://doi.org/10.1038/nrm3522
- Guha P, Kaptan E, Gade P, Kalvakolanu DV and Ahmed H (2017) Tunicamycin induced endoplasmic reticulum stress promotes apoptosis of prostate cancer cells by activating mTORC1. Oncotarget 8, 68191-68207 https://doi.org/10.18632/oncotarget.19277
- Namgung Y, Kim SY and Kim I (2019) Down-regulation of survivin by BIX-01294 pretreatment overcomes resistance of hepatocellular carcinoma cells to TRAIL. Anticancer Res 39, 3571-3578 https://doi.org/10.21873/anticanres.13503